P/E ratio for Integra LifeSciences (IART)

P/E ratio history for Integra LifeSciences from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Stryker Corporation SYK	57.0	198.46%	🇺🇸 USA
Teleflex TFX	22.6	18.05%	🇺🇸 USA
Dentsply Sirona XRAY	-17.4	-190.81%	🇺🇸 USA
CONMED CNMD	39.8	108.39%	🇺🇸 USA
Johnson & Johnson JNJ	10.9	-43.06%	🇺🇸 USA
Medtronic MDT	32.3	69.27%	🇮🇪 Ireland
Cardinal Health CAH	124	549.46%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.